Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus

NCT02077309 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped bad recruitment of suitable participants, just 4 patients in one year

Conditions

Diabetes Mellitus Type 2 (T2DM)
Vascular Inflammation
Plaque Morphology

Interventions

DRUG: Linagliptin
DRUG: Placebo

Sponsor

RWTH Aachen University